Wellstat Therapeutics is a biopharmaceutical company that develops treatments for patients in the fields of oncology, metabolic, neurometabolic, and neurodegenerative diseases. Its pipeline of small molecule therapeutic agents spans the stages of drug discovery, development, and commercialization.